Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenoceptor antagonism and the hyperthyroid rat heart

G Amos1, D Kerr, C Sernia

  • 1Department of Physiology and Pharmacology, University of Queensland, Australia.

Journal of Cardiovascular Pharmacology
|August 1, 1994
PubMed
Summary

Beta-adrenoceptor antagonists like atenolol partially reduce hyperthyroidism symptoms in rats, but do not prevent cardiac hypertrophy or hypertension. These drugs offer limited cardiovascular protection against hyperthyroidism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

ESMO open·2022
Same author

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial.

NPJ digital medicine·2021
Same author

ESMO's new strategic plan: our society's road to the future of oncology.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Predicting changes in the status of patient-reported outcome measures after Birmingham Hip Resurfacing: an observational cohort study with a median follow-up of ten years.

The bone & joint journal·2019
Same author

The outcome and survival of metal-on-metal hip resurfacing in patients aged less than 50 years: a prospective observational cohort study with minimum ten-year follow-up.

The bone & joint journal·2019
Same author

Occupational exposure to methoxyflurane administered for procedural sedation: an observational study of 40 exposures.

British journal of anaesthesia·2018

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pharmacology

Background:

  • Hyperthyroidism causes significant cardiovascular changes, including tachycardia and hypertension.
  • Beta-adrenoceptor antagonists are used to manage hyperthyroid symptoms.
  • The specific impact of beta-blockers on hyperthyroidism-induced cardiac alterations requires further elucidation.

Purpose of the Study:

  • To investigate the efficacy of atenolol in attenuating cardiac changes associated with hyperthyroidism.
  • To assess the effects of atenolol on physiological parameters and cardiac function in a rat model of hyperthyroidism.

Main Methods:

  • Rats were induced into a hyperthyroid state using triiodothyronine (T3).
  • Hyperthyroid rats were treated with atenolol.

Related Experiment Videos

  • Physiological parameters, cardiac contractility, and beta-adrenoceptor density were measured.

    • Main Results:

    • T3-induced hyperthyroidism led to increased metabolism, cardiac hypertrophy, tachycardia, and hypertension.
    • Atenolol treatment attenuated heart rate, temperature, and oxygen consumption increases.
    • Cardiac hypertrophy, hypertension, and altered inotropic responses remained unaffected by atenolol.

    Conclusions:

    • Beta-adrenoceptor antagonists provide only partial amelioration of hyperthyroidism-induced cardiovascular responses.
    • Atenolol did not prevent key cardiovascular risks associated with hyperthyroidism, such as cardiac hypertrophy and hypertension.